0001104659-21-035613.txt : 20210312
0001104659-21-035613.hdr.sgml : 20210312
20210312164003
ACCESSION NUMBER: 0001104659-21-035613
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210310
FILED AS OF DATE: 20210312
DATE AS OF CHANGE: 20210312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wedell-Wedellsborg Johan
CENTRAL INDEX KEY: 0001753185
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38650
FILM NUMBER: 21738058
MAIL ADDRESS:
STREET 1: RUNGSTED STRANDVEJ 113
CITY: RUNGSTED KYST
STATE: G7
ZIP: 2960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc.
CENTRAL INDEX KEY: 0001722964
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474619612
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 THIRD AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-847-9841
MAIL ADDRESS:
STREET 1: 750 THIRD AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
tm218464-3_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-03-10
0
0001722964
Y-mAbs Therapeutics, Inc.
YMAB
0001753185
Wedell-Wedellsborg Johan
C/O WECO GROUP A/S
RUNGSTED STRANDVEJ 113
RUNGSTED KYST
G7
2900
DENMARK
1
0
0
0
Common Stock
2021-03-10
4
J
0
1029927
D
4478465
I
By WG Biotech ApS
WG Biotech Aps transferred 1,029,927 shares of the Common Stock of Y-mAbs Therapeutics, Inc. (the "Company") to GAD Enterprises, LLC in exchange for 20,565 ordinary shares of WG Biotech ApS. The closing sale price of the Company's Common Stock on March 10, 2021, the date of the transaction, was $35.30.
Reporting Person is the majority owner of WG Biotech ApS and as such has sole voting and dispositive power with respect to such shares.
/s/ Johan Wedell-Wedellsborg
2021-03-12